Hhlr Advisors, Ltd. Akero Therapeutics, Inc. Transaction History

Hhlr Advisors, Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.89 - $56.88 $830,025 - $1.28 Million	-22,500 Reduced 7.61%	273,002 $12.7 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $745,400 - $1 Million	-20,000 Reduced 6.34%	295,502 $11.3 Million
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $12.2 Million - $20 Million	-364,498 Reduced 53.6%	315,502 $17.3 Million
Q3 2022 Nov 14, 2022	SELL	$10.15 - $34.05 $6.89 Million - $23.1 Million	-679,052 Reduced 49.97%	680,000 $23.2 Million
Q2 2022 Aug 15, 2022	SELL	$8.0 - $15.01 $800 - $1,501	-100 Reduced 0.01%	1,359,052 $12.8 Million
Q4 2021 Feb 14, 2022	SELL	$19.87 - $26.24 $3.6 Million - $4.76 Million	-181,313 Reduced 11.77%	1,359,152 $28.7 Million
Q3 2021 Nov 15, 2021	SELL	$18.65 - $25.46 $2.17 Million - $2.96 Million	-116,208 Reduced 7.01%	1,540,465 $34.4 Million
Q3 2020 Nov 16, 2020	BUY	$30.79 - $39.92 $18.5 Million - $24 Million	600,000 Added 56.78%	1,656,673 $51 Million
Q2 2020 Aug 14, 2020	BUY	$19.25 - $26.76 $3.19 Million - $4.43 Million	165,472 Added 18.57%	1,056,673 $26.3 Million
Q4 2019 Feb 14, 2020	BUY	$17.37 - $27.27 $2.46 Million - $3.87 Million	141,777 Added 18.92%	891,201 $19.8 Million
Q3 2019 Nov 14, 2019	BUY	$16.89 - $29.88 $5.48 Million - $9.69 Million	324,424 Added 76.34%	749,424 $17 Million
Q2 2019 Aug 14, 2019	BUY	$18.08 - $19.83 $7.68 Million - $8.43 Million	425,000 New	425,000 $8.14 Million

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.45B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.